Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Patient Education and Counseling
|
September 6, 2023
Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health Outcomes Observatory (H2O) programme
Kathryn Hamilton, Rita Forde, Mette Due-Christensen, et al.
Schizophrenia Research
|
July 31, 2017
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment
John Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 2, 2022
Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes
Varo Kirthi, Kate I Reed, Komeil Alattar, et al.
Gut
|
July 24, 2019
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
Annieke C G van Baar, Frits Holleman, Laurent Crenier, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 27, 2019
Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
Fiona Gaughran, Daniel Stahl, Dominic Stringer, et al.
The Lancet. Diabetes & Endocrinology
|
April 27, 2020
Practical recommendations for the management of diabetes in patients with COVID-19
Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, et al.
BMC Psychiatry
|
December 24, 2017
Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion
Margaret Heslin, Anita Patel, Daniel Stahl, et al.
Plos One
|
November 9, 2020
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection
Liam Townsend, Adam H Dyer, Karen Jones, et al.
Cell Death & Disease
|
June 4, 2026
NAMPT activity plays a key role in driving autoimmune processes that mediate beta-cell death and type 1 diabetes development in mice
Daniel Egbase, Sophie R Sayers, Naila Haq, et al.
Diabetes Research and Clinical Practice
|
January 15, 2022
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)
Annieke C G van Baar, Jacques Devière, David Hopkins, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Patient Education and Counseling
|
September 6, 2023
Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health Outcomes Observatory (H2O) programme
Kathryn Hamilton, Rita Forde, Mette Due-Christensen, et al.
Schizophrenia Research
|
July 31, 2017
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment
John Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 2, 2022
Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes
Varo Kirthi, Kate I Reed, Komeil Alattar, et al.
Gut
|
July 24, 2019
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
Annieke C G van Baar, Frits Holleman, Laurent Crenier, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 27, 2019
Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
Fiona Gaughran, Daniel Stahl, Dominic Stringer, et al.
The Lancet. Diabetes & Endocrinology
|
April 27, 2020
Practical recommendations for the management of diabetes in patients with COVID-19
Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, et al.
BMC Psychiatry
|
December 24, 2017
Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion
Margaret Heslin, Anita Patel, Daniel Stahl, et al.
Plos One
|
November 9, 2020
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection
Liam Townsend, Adam H Dyer, Karen Jones, et al.
Cell Death & Disease
|
June 4, 2026
NAMPT activity plays a key role in driving autoimmune processes that mediate beta-cell death and type 1 diabetes development in mice
Daniel Egbase, Sophie R Sayers, Naila Haq, et al.
Diabetes Research and Clinical Practice
|
January 15, 2022
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)
Annieke C G van Baar, Jacques Devière, David Hopkins, et al.
Page
of 9